2.19
price up icon1.86%   0.04
after-market アフターアワーズ: 2.12 -0.07 -3.20%
loading
前日終値:
$2.15
開ける:
$2.19
24時間の取引高:
31,377
Relative Volume:
0.31
時価総額:
$13.46M
収益:
$743.00K
当期純損益:
$-7.63M
株価収益率:
-0.931
EPS:
-2.3523
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-5.60%
1か月 パフォーマンス:
+11.17%
6か月 パフォーマンス:
+4.78%
1年 パフォーマンス:
+0.69%
1日の値動き範囲:
Value
$2.10
$2.275
1週間の範囲:
Value
$2.04
$2.50
52週間の値動き範囲:
Value
$1.83
$4.69

Can-Fite Biopharma Ltd ADR Stock (CANF) Company Profile

Name
名前
Can-Fite Biopharma Ltd ADR
Name
セクター
Healthcare (1182)
Name
電話
972 3 924 1114
Name
住所
10 Bareket Street, Kiryat Matalon PO Box 7537, Petah-Tikva
Name
職員
7
Name
Twitter
@CanFitePharma
Name
次回の収益日
2024-11-28
Name
最新のSEC提出書
Name
CANF's Discussions on Twitter

Can-Fite Biopharma Ltd ADR Stock (CANF) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2017-08-11 開始されました Maxim Group Buy
2016-10-19 再開されました ROTH Capital Buy
2016-08-29 再開されました Rodman & Renshaw Buy
2015-11-30 繰り返されました H.C. Wainwright Buy
2015-03-31 繰り返されました H.C. Wainwright Buy
2015-03-30 ダウングレード ROTH Capital Buy → Neutral
2014-12-29 繰り返されました ROTH Capital Buy
2014-11-18 開始されました H.C. Wainwright Buy
すべてを表示

Can-Fite Biopharma Ltd ADR (CANF) 最新ニュース

pulisher
Nov 04, 2024

Can-Fite secures Australian patent for obesity treatment - Investing.com

Nov 04, 2024
pulisher
Oct 18, 2024

Can-Fite's partner Vetbiolix secures $325M deal for dog arthritis drug - Investing.com India

Oct 18, 2024
pulisher
Oct 16, 2024

Shifts in the Psoriasis Market Suggest Strong Potential for Emerging Oral Therapies - GlobeNewswire Inc.

Oct 16, 2024
pulisher
Sep 25, 2024

Ratios in Focus: Analyzing Can-Fite Biopharma Ltd ADR (CANF)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Sep 25, 2024
pulisher
Sep 24, 2024

What is CANF’s price-to-sales ratio telling us about the company’s value? - US Post News

Sep 24, 2024
pulisher
Sep 02, 2024

Taking on analysts’ expectations and winning: Can-Fite Biopharma Ltd ADR (CANF) - SETE News

Sep 02, 2024
pulisher
Sep 02, 2024

Analytical Lens: Exploring Can-Fite Biopharma Ltd ADR (CANF)’s Financial Story Through Ratios - The Dwinnex

Sep 02, 2024
pulisher
Sep 02, 2024

CANF (Can-Fite Biopharma Ltd ADR) has impressive results - US Post News

Sep 02, 2024
pulisher
Aug 26, 2024

List of Israeli Stocks Traded on the NYSE Worth Considering - The Times of Israel

Aug 26, 2024
pulisher
Aug 23, 2024

Wearable Devices Ltd. sets annual meeting for September 26 - Investing.com

Aug 23, 2024
pulisher
Jul 17, 2024

Can-Fite BioPharma shares upgraded by EF Hutton to Buy on pipeline drugs - Investing.com

Jul 17, 2024
pulisher
Jun 28, 2024

GitLab stock maintains buy rating on new release By Investing.com - Investing.com

Jun 28, 2024
pulisher
Jun 28, 2024

Pacira's (PCRX) Q3 Earnings Miss Estimates, Revenues Beat - Yahoo New Zealand News

Jun 28, 2024
pulisher
Jun 28, 2024

Canine arthritis treatment shows promise in clinical study - Investing.com India

Jun 28, 2024
pulisher
Jun 25, 2024

Can-Fite reveals adiponectin role in cancer treatment By Investing.com - Investing.com

Jun 25, 2024
pulisher
Jun 19, 2024

Was Can-Fite Biopharma Ltd ADR (CANF)'s session last reading good? – US Post News - US Post News

Jun 19, 2024
pulisher
Jun 05, 2024

Can-Fite's Namodenoson gains FDA Fast Track for liver cancer - Investing.com India

Jun 05, 2024
pulisher
Jun 05, 2024

Can-Fite's Namodenoson gains FDA Fast Track for liver cancer By Investing.com - Investing.com

Jun 05, 2024
pulisher
Apr 15, 2024

Can-Fite's Namodenoson advances in Phase III liver cancer trial By Investing.com - Investing.com

Apr 15, 2024
pulisher
Apr 03, 2024

Can-Fite BioPharma seeks FDA nod for NASH drug trial By Investing.com - Investing.com

Apr 03, 2024
pulisher
Jan 05, 2024

ANVS Stock Quote Price and Forecast - CNN

Jan 05, 2024
pulisher
Nov 21, 2023

symbol__ Stock Quote Price and Forecast - CNN

Nov 21, 2023
pulisher
Jul 12, 2023

Liver Cirrhosis Market to Observe Impressive Growth at a CAGR of 6.3% by 2032, Predicts DelveInsight - PR Newswire

Jul 12, 2023
pulisher
Dec 30, 2022

Can-Fite Announces ADS Ratio Change - Business Wire

Dec 30, 2022
pulisher
Nov 10, 2022

Catalyst's (CPRX) Q3 Earnings & Revenues Surpass Estimates - Nasdaq

Nov 10, 2022
pulisher
Oct 19, 2022

Le 1001 azioni che si sono schiantate sul mercato azionario USA - Scenari Economici

Oct 19, 2022
pulisher
Mar 16, 2021

Can-Fite Signs $42.7 Million Out-Licensing Deal with Ewopharma - Business Wire

Mar 16, 2021
pulisher
Feb 25, 2021

Best Penny Stocks Today | Penny Stocks to Buy Now -TipRanksTipRanks.com - TipRanks

Feb 25, 2021
pulisher
Oct 15, 2020

The Daily Biotech Pulse: Vertex Pulls Plug On Protein Deficiency Drug, FDA Nod For Regeneron's Ebola Trea - Benzinga

Oct 15, 2020
pulisher
Sep 16, 2020

Can-Fite BioPharma (CANF) Stock Price, News & Analysis - MarketBeat

Sep 16, 2020
pulisher
Mar 03, 2020

The Daily Biotech Pulse: GenMark Diagnostics Ships COVID-19 Test Kits, Karyopharm To Offer Shares, And Mo - Benzinga

Mar 03, 2020
pulisher
Jan 09, 2020

32 Stocks Moving In Thursday's Mid-Day SessionAEterna Zentaris (NASDAQ:AEZS), ADMA Biologics (NASDAQ:A - Benzinga

Jan 09, 2020
pulisher
Aug 24, 2019

10 Biopharmaceutical Companies Trying To Cure Cancer - Yahoo Finance

Aug 24, 2019
pulisher
Aug 08, 2019

The Daily Biotech Pulse: Glaukos To Buy Avedro, Mixed Adcom Vote For Gilead, Dynavax OfferingiShares B - Benzinga

Aug 08, 2019
pulisher
May 24, 2019

Secondary Offerings Put A Pause On May's MomentumMynd.ai (AMEX:MYND), Can Fite Biofarma (AMEX:CANF) - Benzinga

May 24, 2019
pulisher
Feb 05, 2018

28 Stocks Moving In Monday's Pre-Market Session - Benzinga

Feb 05, 2018
pulisher
Apr 25, 2017

20 Biggest Mid-Day Gainers For TuesdayAlcoa (NYSE:AA), Biogen (NASDAQ:BIIB) - Benzinga

Apr 25, 2017
pulisher
Aug 02, 2016

Can-Fite's Rheumatoid Arthritis Drug Faces Off With Methotrexate In Phase III Trial For $40 Billion Market (NYSE:CANF) - Seeking Alpha

Aug 02, 2016
pulisher
Oct 05, 2015

Propanc Health Group Corp : This Company Could Be the Next CETX or CANF - Marketscreener.com

Oct 05, 2015
pulisher
Sep 17, 2015

Morning Market GainersCan Fite Biofarma (AMEX:CANF) - Benzinga

Sep 17, 2015
pulisher
Oct 04, 2012

Can-Fite BioPharma Begins Trading in U.S. through Launch of ADRs - CNBC

Oct 04, 2012

Can-Fite Biopharma Ltd ADR (CANF) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
大文字化:     |  ボリューム (24 時間):